ArticlePlant, cell & environment2026
CsWRKY33 Integrates Immune Signalling and Metabolic Reprogramming to Enhance Tea Plant Resistance Against Colletotrichum camelliae.
Article in Plant, cell & environment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Tea anthracnose, caused by Colletotrichum camelliae, poses a serious threat to tea yield and quality. While certain transcription factors have been implicated in stress responses, the core transcriptional networks governing immunity in tea plants remain largely elusive. In this study, we identify CsWRKY33 as a central regulator that orchestrates immune responses and metabolic reprogramming during C. camelliae infection in tea plants. Transcriptome analysis revealed that CsWRKY33 is significantly induced upon fungal challenge and functions downstream of both pattern-triggered immunity (PTI) and effector-triggered immunity (ETI). Mechanistically, protein-promoter affinity experiments demonstrated that CsWRKY33 directly binds to W-box motifs in the promoters of key immune genes, including CsSERK2, CsMPK3, CsCDPK32, CsPR1B, CsWIN2 and CsRPM1. Dual-luciferase assays and functional validations further confirmed that CsWRKY33 activates its expression, forming a positive feedback loop that amplifies immune signalling. Concurrently, CsWRKY33 modulates primary metabolism by repressing photosynthetic genes such as CsRCA and enhances secondary metabolism by directly activating phenylpropanoid pathway genes such as CsPAL and CsCAD1. These coordinated transcriptional programmes reallocate energy and resources toward defence, thereby enhancing resistance. We propose a working model in which CsWRKY33 serves as a transcriptional hub linking immune activation with metabolic adjustment to facilitate efficient defence. This study provides new insights into WRKY-mediated immunity in perennial woody plants and highlights CsWRKY33 as a promising target for molecular breeding of anthracnose-resistant tea cultivars.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.